UN ENSAYO ALEATORIZADO INTERNACIONAL PARA EVALUAR TRATAMIENTOS NO LICENCIADOS PARA COVID-19 EN PACIENTES HOSPITALIZADOS QUE RECIBEN EL TRATAMIENTO CONVENCIONAL PARA COVID QUE SE OFRECE EN CADA HOSPITAL.
Datos básicos
- Código:
- OMS COVID-19
- Protocolo:
- OMS COVID-19
- EUDRACT:
- 2020-001366-11
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Dotación:
- Año de incio:
- 2020
- Año de finalización:
- 2020
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
Resultados del Ensayo Clínico
[Translated article] Cybersecurity: a priority for pharmacy services in the age of artificial intelligence
Marin, Cayetano M. Hernandez, Monte-Boquet, Emilio, Andres, Jose Luis Poveda
Editorial Material. 10.1016/j.farma.2024.08.009. 2024
[Translated article] Good humanisation practices in the healthcare of patients with rare diseases in Pharmacy Services
Company Albir MJ, Andrés JLP, Solsona MDE
Article. 10.1016/j.farma.2023.10.004. 2024
[Translated article] New challenges in advanced therapies.
Megías-Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.farma.2024.05.001. 2024
[Translated article] Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice.
Chovi-Trull, Maria; (...); Andres, Jose Luis Poveda
Article. 10.1016/j.farma.2024.12.007. 2025
[Translated article] Real-world effectiveness and safety of nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma.
Fernandez, Laura Lorente; (...); Andres, Jose Luis Poveda
Article. 10.1016/j.farma.2024.09.006. 2024
2019 SEFH National Survey: service portfolio, care activities, education and research in Spain's hospital pharmacy departments.
Pérez-Encinas M; (...); Calleja-Hernández MÁ
Article. 10.7399/fh.11611. 2021
A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain
Zozaya, Neboa; (...); Hidalgo-Vega, Alvaro
Article. 10.33393/grhta.2022.2333. 2022
A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases.
Zozaya, Neboa; (...); Verde, Luis
Article. 10.1017/S0266462322000459. 2022
A new definition and refocus of pharmaceutical care: the Barbate Document
Morillo-Verdugo R; (...); Poveda-Andrés JL
Article. 10.7399/fh.11389. 2020
A NKp80-Based Identification Strategy Reveals that CD56 neg NK Cells Are Not Completely Dysfunctional in Health and Disease.
Orrantia A; (...); Borrego F
Article. 10.1016/j.isci.2020.101298. 2020
A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes.
Santos JR; (...); Paredes R
Article. 10.1093/ofid/ofad542. 2023
A survey to describe common practices on antifungal monitoring among Spanish clinicians.
Gomez-Lopez, Alicia, Martin-Gomez, Maria Teresa, Salavert Lleti, Miguel
Article. 10.1016/j.eimc.2021.05.009. 2021
A survey to describe common practices on antifungal monitoring among Spanish clinicians.
Gomez-Lopez, Alicia, Martin-Gomez, Maria Teresa, Salavert Lleti, Miguel
Article. 10.1016/j.eimce.2021.05.020. 2023
Analysis of chemical contamination by hazardous drugs with BD HD Check(R) system in a tertiary hospital
Valero García S; (...); Poveda Andrés JL
Article. 10.1177/10781552211038518. 2021
Anti-neutrophil cytoplasmic antibody-positive vasculitis presenting with periaortitis and muscle vasculitis in a patient with chronic Chagas disease: comment on the letter by Garcia-Bustos et al Reply
Garcia-Bustos V; (...); Moral Moral P
Letter. 10.1080/03009742.2020.1756401. 2020
Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA).
Pereyra-Rodríguez JJ; (...); Ortiz de Frutos FJ
Letter. 10.1111/jdv.19432. 2023
Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.
Iglesias Gómez R; (...); Poveda Andrés JL
Article. 10.1136/ejhpharm-2021-002741. 2021
Bictegravir/emtricitabine/tenofovir alafenamide as first-line treatment in naïve HIV patients in a rapid-initiation model of care: BIC-NOW clinical trial.
Tenorio CH; (...); Vallecillos CG
Article. 10.1016/j.ijantimicag.2024.107164. 2024
Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study.
Fernandez Rivera C; (...); Hernandez D
Article. 10.1111/ctr.14550. 2022
Candent issues in pneumonia. Reflections from the Fifth Annual Meeting of Spanish Experts 2023
Rodriguez-Leal, Cristobal M.; (...); Salavert, Miguel
Review. 10.37201/req/018.2024. 2024
Cefto Real-Life Study: Real-World Data on the Use of Ceftobiprole in a Multicenter Spanish Cohort.
Hidalgo-Tenorio, Carmen; (...); Sadyrbaeva-Dolgova, Svetlana
Article. 10.3390/antibiotics12071218. 2023
Circulating extracellular vesicles in sera of chronic patients as a method for determining active parasitism in Chagas disease
Lozano, Noelia; (...); Osuna, Antonio
Article. 10.1371/journal.pntd.0012356. 2024
Climate change, animals, and Candida auris: insights into the ecological niche of a new species from a one health approach.
Garcia-Bustos, Victor; (...); Peman, Javier
Article. 10.1016/j.cmi.2023.03.016. 2023
Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients
Megias-Vericat, JE; (...); Poveda, JL
Article. 10.1016/j.thromres.2021.07.009. 2021
Clinical management of cUTI, cIAI, and HABP/VABP attributable to carbapenem-resistant Gram-negative infections in Spain
Ferrer, Ricard; (...); McCann, Eilish
Article. 10.37201/req/096.2021. 2021
Clinicopathological characteristics of cutaneous and mucocutaneous leishmaniasis in patients treated with TNF-alpha inhibitors.
Palacios-Diaz, Rodolfo David; (...); Botella-Estrada, Rafael
Article. 10.1111/ddg.15007. 2023
CMV REACTIVATIONS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT FROM HLA-MATCHED AND HAPLOIDENTICAL DONORS WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE.
Article. 10.1016/j.jtct.2024.01.082. 2024
Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study
Babich, T; (...); Yahav, D
Article. 10.1093/jac/dkab134. 2021
Common seasonal respiratory virus infections in allogeneic stem cell transplant recipients during the SARS-COV-2 pandemic.
De La Puerta R; (...); Piñana JL
Article. 10.1038/s41409-021-01319-5. 2021
Community acquired respiratory virus infections in adult patients undergoing umbilical cord blood transplantation.
Montoro J; (...); Piñana JL
Article. 10.1038/s41409-020-0943-0. 2020
Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.
Montoro-Ronsano JB; (...); Soto-Ortega I
Article. 10.1016/j.farma.2023.01.003. 2023
Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.
Montoro-Ronsano, Jose Bruno; (...); Soto-Ortega, Inmaculada
Article. 10.1016/j.farma.2023.04.002. 2023
Corrigendum to "Safety and effectiveness of isavuconazole in real-life non-neu tropenic patients" [International Journal of Infectious Diseases 144 (2024) 107070].
Monzó-Gallo P; (...); Garcia-Vidal C
Correction. 10.1016/j.ijid.2024.107188. 2024
COST-EFFECTIVENESS ANALYSIS OF DIFELIKEFALIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE ASSOCIATED-PRURITUS IN SPAIN
Sanchez-Alvarez, Emilio E.; (...); Hernaez Colque, M.
Meeting Abstract. 2024
COSTS OF THE MANAGEMENT OF HEMOPHILIA A WITH INHIBITORS IN SPAIN
Bonanad, S; (...); Gonzalez-Dominguez, A
Meeting Abstract. 2020
Costs of the management of hemophilia A with inhibitors in Spain
Bonanad, S; (...); Gonzalez-Dominguez, A
Article. 10.33393/grhta.2021.2234. 2021
CT GUIDED NEEDLE BIOPSY IN VERTEBRAL OSTEOMYELITIS: RELIABILITY ANALYSIS AND STUDY OF WHICH FACTORS COULD INFLUENCE ON THE RESULT
Fragio-Gil, J. J.; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2020-eular.6383. 2020
CT-Guided Needle Biopsy in Vertebral Osteomyelitis: Study of Factors That Could Influence in Culture Yield.
Fragío Gil JJ; (...); Román Ivorra JA
Article. 10.1016/j.reumae.2020.08.007. 2022
CT-Guided Needle Biopsy in Vertebral Osteomyelitis: Study of Factors That Could Influence in Culture Yield
Fragio Gil, Jorge Juan; (...); Roman Ivorra, Jose Andres
Article. 10.1016/j.reuma.2020.08.002. 2022
Current approach to skin and soft tissue infections. Thinking about continuity of care.
Blanes Hernández R; (...); Salavert Lletí M
Article. 10.37201/req/s01.10.2023. 2023
Current management of CMV infection in cancer patients (solid tumors). Epidemiology and therapeutic strategies.
Garcia-Bustos, Victor; (...); Blanes, Marino
Article. 10.37201/req/s03.16.2022. 2022
Current Positioning against Severe Infections Due to Klebsiella pneumoniae in Hospitalized Adults.
Vidal-Cortes, Pablo; (...); Zaragoza, Rafael
Review. 10.3390/antibiotics11091160. 2022
Cybersecurity, a priority for pharmacy services in the age of artificial intelligence.
Hernández Marín CM, Monte-Boquet E, Poveda Andrés JL
Editorial Material. 10.1016/j.farma.2024.08.001. 2024
Cytokine response as a biomarker for early diagnosis and outcome prediction of stem cell transplant recipients and acute leukemia patients with invasive aspergillosis.
Puerta-Alcalde, Pedro; (...); Garcia-Vidal, Carolina
Article. 10.1093/mmy/myac038. 2022
Characterization of the Differential Pathogenicity of Candida auris in a Galleria mellonella Infection Model.
Garcia-Bustos V; (...); Pemán J
Article. 10.1128/Spectrum.00013-21. 2021
Dalbavancin in clinical practice in Spain: a 2 year retrospective study.
Morata, Laura; (...); Almirante, Benito
Article. 10.1093/jacamr/dlac120. 2022
Dalbavancin real-life utilization among diabetic patients suffering from infections in Italy and Spain: The DALBADIA retrospective cohort study.
Morata Ruiz L; (...); Grossi PA
Article. 10.1016/j.jgar.2023.11.015. 2024
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57).
Podzamczer D; (...); Moreno S
Article. 10.1093/ofid/ofab595. 2022
Decalogue for the selection of oral antibiotics for lower respiratory tract infections
Canton, Rafael; (...); Gonzalez del Castillo, Juan
Article. 10.37201/req/172.2021. 2022
Design and rationale for a real-world prospective, multicenter registry of myocardial revascularization failure and secondary revascularization: The REVASEC study.
Salinas P; (...); Escaned J
Article. 10.1016/j.carrev.2021.11.015. 2021
Determining value in the treatment of activated PI3Kdelta syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.
Abad, Maria Reyes; (...); Gil, Alicia
Article. 10.33393/grhta.2024.3041. 2024
Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis
Silvestre, Juan Francisco; (...); Serra-Baldrich, Esther
Article. 10.1002/jvc2.275. 2024
Differences in epidemiology and mortality between men and women with HIV infection in the CoRIS cohort from 2004 to 2014.
Muñoz Hornero C; (...); Pérez-Elías MJ
Article. 10.1016/j.eimc.2020.05.021. 2021
Differences in epidemiology and mortality between men and women with HIV infection in the CoRIS cohort from 2004 to 2014.
Muñoz Hornero C; (...); Pérez-Elías MJ
Article. 10.1016/j.eimce.2021.07.003. 2021
Disseminated toxoplasma infection after hematopoietic stem cell transplantation with myositis and encephalitis.
Asensi Cantó P; (...); Guerreiro M
Article. 10.1111/tid.14067. 2023
Does Autoimmunity Play a Role in the Immunopathogenesis of Vasculitis Associated With Chronic Chagas Disease?
Garcia-Bustos, V; (...); Munoz, EC
Editorial Material. 10.3389/fcimb.2021.671962. 2021
DOLAVI Real-Life Study of Dolutegravir Plus Lamivudine in Naive HIV-1 Patients (48 Weeks).
Hidalgo-Tenorio, Carmen; (...); Garcia-Vallecillos, Coral
Article. 10.3390/v14030524. 2022
Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study.
Troya, Jesus; (...); Buzon, Luis
Article. 10.1097/MD.0000000000029252. 2022
Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study.
Babich T; (...); Yahav D
Article. 10.1007/s40121-022-00657-1. 2022
Dynamics of creatinine estimated glomerular filtration rate using one or more antiretrovirals that inhibit creatinine tubular secretion.
Perez Elias MJ; (...); Martinez E
Article. 10.1093/jac/dkaa547. 2021
Dysimmunity in common variable immunodeficiency is associated with alterations in oral, respiratory, and intestinal microbiota.
Cabanero-Navalon, Marta Dafne; (...); Carda-Dieguez, Miguel
Article. 10.1016/j.clim.2023.109796. 2023
Early Detection of Cancer and Precancerous Lesions in Persons with HIV through a Comprehensive Cancer Screening Protocol.
Gutierrez, Felix; (...); Masia, Mar
Article. 10.1093/cid/ciae359. 2024
Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies.
Moreno-Garcia, E; (...); Garcia-Vidal, C
Article. 10.1093/ofid/ofab250. 2021
Economic burden of recurrent Clostridioides difficile infection in adults admitted to Spanish hospitals. A multicentre retrospective observational study
Bouza, E; (...); Limon, E
Article. 10.37201/req/135.2020. 2021
Efecto de la adición de fortificantes y de módulo de proteínas en la osmolalidad de la leche materna donada.
Torres Martínez E; (...); Vento M
Article. 10.1016/j.anpedi.2020.03.009. 2020
Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients
Cordero, E; (...); Perez-Romero, P
Article. 10.3389/fimmu.2020.01917. 2020
Effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in HIV late presenters
Corona, Diana; (...); Rivero, Antonio
Article. 10.1016/j.ijantimicag.2023.107016. 2024
Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study.
Santos JR; (...); Paredes R
Article. 10.3389/fcimb.2023.1187999. 2023
Effectiveness and tolerability of dolutegravir and abacavir/lamivudine administered as two separate pills compared to their equivalent single-tablet regimen in treatment-naive and treatment-experienced patients
Suarez-Garcia, I.; (...); Jarrin, I.
Meeting Abstract. 2021
Effectiveness of Caplacizumab Nanobody in Acquired Thrombotic Thrombocytopenic Purpura Refractory to Conventional Treatment
Palanques-Pastor T; (...); Poveda Andrés JL
Article. 10.1159/000517813. 2021
Efficacy and safety of dolutegravir/rilpivirine in real-world clinical practice. GeSIDA study 1119.
Palacios, R.; (...); Santos, J.
Article. 10.1111/hiv.13489. 2023
eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort
Teira, R; (...); Espinosa, N
Article. 10.1080/25787489.2021.1955197. 2021
Enterococcus spp. and Streptococcus spp. bloodstream infections: epidemiology and therapeutic approach.
Blanes Hernández R, Blanes Juliá M
Article. 10.37201/req/s01.01.2023. 2023
Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019.
Fanciulli C; (...); González Garcia J
Article. 10.1111/hiv.13229. 2022
Epidemiology and clinical description of Chagas disease in Valencia, Spain, from 2010 to 2020
Lozano, Noelia; (...); Calabuig, Eva
Article. 10.1016/j.actatropica.2024.107458. 2024
Etiology, diagnosis, and management of pneumonia in immunosuppressed patients.
Salavert Lleti, Miguel; (...); Garcia-Bustos, Victor
Article. 10.37201/req/s01.20.2022. 2022
Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2.
Ruiz-Rodriguez P; (...); Coscolla M
Article. 10.1128/mBio.02315-21. 2021
Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2.
Candel, Francisco Javier; (...); On Behalf Of The Modus Investigators Adenda
Article. 10.3390/v15071449. 2023
Factors associated with late presentation for HIV care in adolescents in Spain
Epalza, Cristina; (...); Luisa Navarro, Maria
Article. 10.1111/hiv.13407. 2022
Fetal exposure to tofacitinib during the first trimester: A healthy newborn case report
Fernandez-Sanchez, M; (...); Poveda-Andres, JL
Article. 10.1002/bdr2.1942. 2021
Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort study
Escudero-Sanchez, Rosa; (...); Cobo Reinoso, Javier
Article. 10.1093/jac/dkac106. 2022
Frequency and characteristics of HTLV in migrants: Results from the +Redivi collaborative network in Spain.
Norman FF; (...); López-Vélez R
Article. 10.1093/jtm/taac019. 2022
Fungal co-infection in COVID-19 patients: Should we be concerned?
Pemán J; (...); Quindós G
Review. 10.1016/j.riam.2020.07.001. 2020
Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review.
Plaza J; (...); Moret-Tatay I
Article. 10.3390/ijms25073717. 2024
Guide to Good Humanization Practices in Patients with Rare Diseases. who vadis
Editorial Material. 2022
Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study
Solana-Altabella, Antonio; (...); Martinez-Cuadron, David
Article. 10.3390/cancers14081921. 2022
High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis.
El-Qutob D; (...); Carrera-Hueso FJ
Article. 10.1016/j.hrtlng.2022.02.003. 2022
HIV/HBV coinfection: temporal trends and patient characteristics, Spain, 2002 to 2018
Perez-Latorre, L; (...); Gonzalez-Garcia, J
Article. 10.2807/1560-7917.ES.2021.26.25.2000236. 2021
Hospital pharmacy initiatives for improving the management of patients with congenital coagulopathies
Bruno Montoro-Ronsano, Jose; (...); Alberto Vella, Vincenzo
Article. 10.7399/fh.11729. 2022
Hospitalization budget impact during the COVID-19 pandemic in Spain.
Carrera-Hueso, F. J.; (...); Crespo-Palomo, C.
Article. 10.1186/s13561-021-00340-0. 2021
Host-pathogen interactions upon Candida auris infection: fungal behaviour and immune response in Galleria mellonella
Garcia-Bustos, Victor; (...); Ruiz-Sauri, Amparo
Article. 10.1080/22221751.2021.2017756. 2022
How can artificial intelligence optimize value-based contracting?
Poveda, Jose Luis; (...); Medrano, Ignacio H.
Letter. 10.1186/s40545-022-00475-3. 2022
How can we optimize the diagnostic and therapeutic approach of pneumonia? Expert opinion-based recommendations
Fernandez-Ruiz, Mario; (...); Aguado, Jose Maria
Article. 10.1016/j.eimc.2024.06.003. 2024
How can we optimize the diagnostic and therapeutic approach to pneumonia? Expert opinion-based recommendations.
Fernandez-Ruiz, Mario; (...); Abril, Vicente
Article. 10.1016/j.eimce.2024.07.001. 2024
How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort
Suarez-Garcia, I; (...); Hernando, V
Article. 10.1186/s12905-021-01370-w. 2021
Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection.
Masiá M; (...); Martínez E
Article. 10.1186/s13063-021-05777-6. 2021
Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection (vol 22, 851, 2021)
Masia, M.; (...); Martinez, E.
Correction. 10.1186/s13063-023-07655-9. 2023
Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.
Megías-Vericat JE; (...); Montesinos P
Article. 10.1080/10428194.2020.1839650. 2020
Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients
Merchante, N; (...); Pineda, JA
Article. 10.1097/QAD.0000000000002578. 2020
Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019
Badia X; (...); Hernández C
Article. 10.1186/s13023-020-01507-4. 2020
Improvements in Patient-Reported Outcomes After 12 Months of Maintenance Therapy With Cabotegravir+Rilpivirine Long-Acting Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide in the Phase 3b SOLAR Study.
Mussini, Cristina; (...); van Wyk, Jean
Article. 10.1007/s10461-024-04490-0. 2024
Incidence, risk factors, and outcomes of BK hemorrhagic cystitis in hematopoietic stem cell transplantation from HLA-matched and haploidentical donors with post-transplant cyclophosphamide.
Chorao, Pedro; (...); Sanz, Jaime
Article. 10.1016/j.jtct.2024.12.006. 2024
Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia.
Megías-Vericat JE; (...); Montesinos P
Article. 10.1097/FPC.0000000000000431. 2021
Invasive Fusariosis in Nonneutropenic Patients, Spain, 2000-2015
Perez-Nadales, E; (...); Spanish Fusariosis Study Grp
Article. 10.3201/eid2701.190782. 2021
IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors.
Álvarez H; (...); Poveda E
Article. 10.3389/fimmu.2023.1257725. 2023
Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.
Pozo-Rosich P; (...); Irimia P
Article. 10.1186/s10194-024-01747-w. 2024
Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety.
Martin-Cerezuela, Maria; (...); Ramirez Galleymore, Paula
Article. 10.3390/antibiotics13080706. 2024
Klinisch-pathologische Eigenschaften kutaner und mukokutaner Leishmaniose bei mit TNF-a-Inhibitoren behandelten Patienten.
Palacios-Diaz, Rodolfo David; (...); Botella-Estrada, Rafael
Article. 10.1111/ddg.15007_g. 2023
Knowledge, attitudes and practices in HIV-related chronic inflammation and cardiovascular risk in Spain
Serrano-Villar, Sergio; (...); de Isla, Leopoldo Perez
Article. 10.1016/j.eimc.2023.07.005. 2024
Knowledge, attitudes and practices in HIV-related chronic inflammation and cardiovascular risk in Spain.
Serrano-Villar, Sergio; (...); Perez de Isla, Leopoldo
Article. 10.1016/j.eimce.2023.07.009. 2023
Laboral Cranio-Facial Cellulitis with Perichondritis and External Otitis, A Case Report
Moreno, Eloy Sempere, Barcelo, Santos Ibanez, Alonso, Marta Montero
Editorial Material. 10.1016/j.eimc.2024.02.008. 2024
Laboral cranio-facial cellulitis with perichondritis and external otitis, a case report.
Sempere Moreno, Eloy, Ibanez Barcelo, Santos, Montero Alonso, Marta
Case Reports. 10.1016/j.eimce.2024.04.004. 2024
Lack of evidence for infectious SARS-CoV-2 in feces and sewage
Albert, Sandra; (...); Domingo-Calap, Pilar
Article. 10.1007/s10096-021-04304-4. 2021
Linking Microbiota Profiles to Disease Characterization in Common Variable Immunodeficiency: The Case of Granulomatous-Lymphocytic Interstitial Lung Disease.
Cabanero-Navalon MD; (...); Garcia-Bustos V
Article. 10.3390/biomedicines12102239. 2024
Long or complicated mpox in patients with uncontrolled HIV infection.
Corma-Gómez A; (...); Macías J
Article. 10.1002/jmv.29511. 2024
Long term follow-up in HCV infected patients with end stage chronic kidney disease after DAA therapy
Martinez-Camprecios, J; (...); Buti, M
Meeting Abstract. 2021
Long-term evolution in liver disease markers and immune and lipid profiles in vertically HIV/HCV-coinfected youths with sustained viral response after direct-acting antivirals therapy.
Tarancon-Diez, Laura; (...); Muñoz-Fernández MÁ
Article. 10.1016/j.biopha.2023.114587. 2023
Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy
Martinez-Camprecios, Joan; (...); Buti, Maria
Article. 10.1016/j.gastrohep.2022.12.004. 2023
Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV( vol 106, pg 136, 2024)
Pelchen-Matthews, Annegret; (...); Wyatt, Christina M.
Correction. 10.1016/j.kint.2024.10.002. 2024
Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV.
Pelchen-Matthews, Annegret; (...); Wyatt, Christina M.
Article. 10.1016/j.kint.2024.04.010. 2024
Management of flexible cavovarus foot in patients with Charcot-Marie-Tooth disease: midterm results.
Megías-Vericat JE; (...); Poveda-Andrés JL
Article. 2021
Manipulación de fármacos para su administración por gastrostomía endoscópica percutánea en pacientes con esclerosis lateral amiotrófica y nutrición enteral.
Vázquez Polo A; (...); Vázquez Costa JF
Article. 10.20960/nh.03946. 2022
Matching-Adjusted Indirect Comparison of Efficacy and Consumption of rVIII-SingleChain Versus Two Recombinant FVIII Products Used for Prophylactic Treatment of Adults/Adolescents with Severe Haemophilia A
Bonanad, S; (...); Santos, S
Article. 10.1007/s12325-021-01853-0. 2021
Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.
Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor
Article. 10.3390/cancers14030596. 2022
Metyrapone as treatment in the neonatal McCune-Albright syndrome
de Mingo, Carmen; (...); Garcia-Robles, Ana
Article. 10.1515/jpem-2020-0036. 2020
Mitral repair results in endocarditis
Dominguez-Massa, C; (...); Montero-Argudo, JA
Article. 10.1016/j.circv.2020.08.005. 2020
Monitoring coagulation factors during surgery. A systematic review
Eduardo Megias-Vericat, Juan; (...); Luis Poveda-Andres, Jose
Review. 10.7399/fh.11766. 2021
Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH).
Valero-García S; (...); Delgado-Sánchez O
Article. 10.7399/fh.11655. 2021
Monocyte Activation and Ageing Biomarkers in the Development of Cardiovascular Ischaemic Events or Diabetes in People with HIV.
Bernardino, Jose I.; (...); Rodes, Berta
Article. 10.3390/microorganisms11071818. 2023
Mortality in Perinatally HIV-infected Adolescents After Transition to Adult Care in Spain.
Berzosa Sánchez A; (...); Ramos Amador JT
Article. 10.1097/INF.0000000000003009. 2021
Mucormycosis: Current and future management perspective
Gomez, MTM, Lleti, MS
Article. 10.1016/j.riam.2021.04.003. 2021
Multidrug resistant bacterial infections after liver transplantation: prevalence, impact and associated risk factors
Martin-Mateos, Rosa; (...); Albillos, Agustin
Meeting Abstract. 2022
Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors.
Martin-Mateos R; (...); Albillos A
Article. 10.1016/j.jhep.2024.02.023. 2024
Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments
Gomez-Cebrian, N; (...); Pineda-Lucena, A
Review. 10.3390/cancers13184544. 2021
National Survey of the SEFH-2019: portfolio of services, healthcare activity, teaching and research in Hospital Pharmacy Services in Spain (vol 45, pg 32, 2021)
Perez-Encinas, Montserrat; (...); Angel Calleja-Hernandez, Miguel
Correction. 10.7399/fh.11740. 2021
National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies
Eduardo Megias, Juan; (...); Poveda Andres, Jose Luis
Meeting Abstract. 10.1182/blood-2022-169938. 2022
New challenges of advanced therapies.
Megías-Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.farma.2023.11.008. 2024
Norovirus infection as a model of chronic or recurrent infection in common variable immunodeficiency.
Moral Moral, Pedro; (...); Salavert Lleti, Miguel
Article. 10.37201/req/s03.14.2022. 2022
Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus
Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis
Article. 10.1097/MD.0000000000032208. 2022
ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain.
Poveda JL; (...); Badia X
Article. 10.1186/s13023-022-02610-4. 2023
Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes
Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor
Review. 10.3390/biology12091159. 2023
OPTIMIZING MANAGEMENT AND OUTCOMES OF ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS) IN SPAIN: BEWAYAPDS PROJECT
Flores-Moreno, S.; (...); Gil, A.
Meeting Abstract. 2024
Papel de cefditoreno en el tratamiento de las infecciones comunitarias de piel y tejidos blandos: revisando la evidencia.
Cabañero-Navalón MD, García-Bustos V, Salavert Lletí M
Review. 10.37201/req/063.2021. 2021
Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol
Garcia-Robles, Ana; (...); Carrascosa, MA
Article. 10.3389/fped.2020.00372. 2020
Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol (vol 8, 372, 2020)
Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta
Correction. 10.3389/fped.2021.834454. 2022
Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project
Morillo-Verdugo, R; (...); Diaz-Olmo, J
Article. 10.7399/fh.11719. 2021
Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project.
Morillo-Verdugo R; (...); Díaz-Olmo J
Article. 2021
Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.
Ballesta-Lopez, Octavio; (...); Poveda-Andres, Jose Luis
Article. 10.3390/ijms26041760. 2025
Pharmacometabolomics by NMR in Oncology: A Systematic Review.
Gómez-Cebrián N; (...); Pineda-Lucena A
Article. 10.3390/ph14101015. 2021
Pharmacotherapeutic management of advanced therapy medicinal products
Luis Poveda-Andres, Jose; (...); Valero-Garcia, Silvia
Article. 10.7399/fh.13036. 2022
Preparación y administración de perfusiones de insulina en neonatología: Encuesta nacional.
García-Robles A; (...); Aguar-Carrascosa M
Letter. 10.1016/j.anpedi.2020.06.008. 2021
Preparation and administration of insulin infusions in neonatology: A national survey.
Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta
Article. 10.1016/j.anpede.2020.06.015. 2021
Presence of good humanization practices in the healthcare of patients with rare diseases in Pharmacy Services
Company Albir MJ, Poveda Andrés JL, Edo Solsona MD
Article. 10.1016/j.farma.2023.06.0131130. 2024
Prevalence of people living with multidrug-resistant HIV and limited treatment options in Spain.
Llibre, Josep M; (...); Alcantara, Felipe Rodriguez
Article. 10.1111/hiv.13650. 2024
Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotyping.
Casadellà M; (...); Noguera-Julian M
Article. 10.1093/jac/dkaa349. 2020
Proactive therapeutic drug monitoring and pharmacogenetic analysis in inflammatory bowel disease: A systematic review
Ballesta-Lopez, Octavio; (...); Luis Poveda-Andres, Jose
Review. 10.7399/fh.11780. 2021
Prospective cohort study on hospitalised patients with suspected urinary tract infection and risk factors por multidrug resistance.
Garcia-Bustos V; (...); Lletí MS
Article. 10.1038/s41598-021-90949-2. 2021
Prospective study for the early detection of lung carcinoma in patients with HIV infection (GESIDA study 8815).
Valencia ME; (...); González J
Article. 10.1016/j.eimce.2024.05.005. 2024
Psychological distress in women and men living with HIV in Spain: a cross-sectional telephone survey
Garriga, C; (...); Rodriguez-Arenas, MA
Article. 10.1136/ebmental-2019-300138. 2020
Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIV.
Teira, Ramon; (...); Berenguer, Juan
Article. 10.1371/journal.pone.0249515. 2021
Real-life experience with fidaxomicin in Clostridioides difficile infection: a multicentre cohort study on 244 episodes.
Escudero-Sánchez R; (...); Cobo J
Article. 10.1007/s15010-020-01567-5. 2021
Recent infections among newly diagnosed cases of HIV infection in Spain, 2015-2016. National estimates using cohort data.
Hernando V; (...); CoRIS-HIV Biobank
Article. 10.1080/23744235.2021.1893377. 2021
Recommendations for antibiotic selection for severe nosocomial infections
Mensa, Josep; (...); Soriano, Alex
Article. 10.37201/req/126.2021. 2021
Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper.
Los-Arcos I; (...); Ruiz-Camps I
Review. 10.1007/s15010-020-01521-5. 2020
Recommendations on the use of azole antifungals in hematology-oncology patients
Azanza, Jose Ramon; (...); Gutierrez, Carlos Duenas
Review. 10.37201/req/013.2023. 2023
Reduction in the risk of progression of solid organ transplant recipients infected by SARS-CoV-2 treated with monoclonal antibodies
Javier Candel, Francisco; (...); Cuervo Pinto, Rafael
Review. 10.37201/req/023.2023. 2023
Response to Vaccines in Patients with Immune-Mediated Inflammatory Diseases: A Narrative Review.
Garcillan, Beatriz; (...); Diaz-Castroverde, Sabela
Article. 10.3390/vaccines10020297. 2022
Rickettsioses imported by travellers and migrants to Spain attended in the+Redivi network, 2009-2020.
Llenas-Garcia, Jara; (...); Perez-Molina, Jose A.
Article. 10.1093/jtm/taad050. 2023
Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study
Salto-Alejandre, S; (...); Cordero, E
Article. 10.1371/journal.pone.0250796. 2021
Role of previous systemic antibiotic therapy on the probability of recurrence after an initial episode of Clostridioides difficile infection treated with vancomycin.
Merchante, Nicolas; (...); Merino, Esperanza
Article. 10.1093/jacamr/dlad033. 2023
Safety and effectiveness of isavuconazole in real-life non-neutropenic patients.
Monzo-Gallo, Patricia; (...); Garcia-Vidal, Carolina
Article. 10.1016/j.ijid.2024.107070. 2024
Safety and Tolerability of More than Six Days of Tedizolid Treatment
Vendrell, MM; (...); Viladomiu, AS
Article. 10.1128/AAC.00356-20. 2020
SARS-CoV-2 N protein IgG antibody detection employing nanoporous anodized alumina: A rapid and selective alternative for identifying naturally infected individuals in populations vaccinated with spike protein (S)-based vaccines
Esteve-Sanchez, Yoel; (...); Climent, Estela
Article. 10.1016/j.snb.2024.136378. 2024
SARS-COV-2 viral RNA detection through oligonucleotide-capped nanoporous anodic alumina supports.
Lopez-Palacios, Alba; (...); Climent, Estela
Article. 10.1016/j.snr.2025.100298. 2025
SEFH National Survey-2019: general characteristics, staffing, material resources and information systems in Spain's hospital pharmacy departments.
Pérez-Encinas M; (...); Calleja-Hernández MÁ
Article. 10.7399/fh.11565. 2020
Sex differences in hospitalized adult patients with cellulitis: A prospective, multicenter study.
Collazos J; (...); Asensi V
Article. 10.1016/j.ijid.2021.01.044. 2021
Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort
Teira, Ramon; (...); Curran, Adria
Article. 10.1007/s40121-022-00630-y. 2022
SMPTall man lettering application in medication information systems as a quality and safety strategy in hospital organization
Iglesias Gomez, Ruben; (...); Poveda Andres, Jose Luis
Article. 10.1111/jcpt.13703. 2022
Switching to bictegravir/ emtricitabine/tenofovir alafenamide plus darunavir/cobicistat in heavily antiretroviralexperienced, virologically suppressed HIV-infected adults receiving complex regimens: 48-week analysis
Podzamczer, D.; (...); Rivero, A.
Meeting Abstract. 2023
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens.
Podzamczer, Daniel; (...); Rivero, Antonio
Article. 10.1093/jac/dkad285. 2023
Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia
Megías-Vericat JE; (...); Montesinos P
Review. 10.3390/pharmaceutics14040878. 2022
Tedizolid: new data and experiences for clinical practice.
Salavert Lleti, M; (...); Cabanero-Navalon, M D
Article. 10.37201/req/s01.06.2021. 2021
Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review.
Candel, Francisco Javier; (...); Serrano, Leyre
Article. 10.3390/jcm12216864. 2023
Ten Issues to Update in Nosocomial or Hospital-Acquired Pneumonia: An Expert Review.
Candel, Francisco Javier; (...); Zaragoza, Rafael
Article. 10.3390/jcm12206526. 2023
The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity
Garcia-Robles, Ana; (...); Saenz Gonzalez, Pilar
Article. 10.1007/s00431-022-04628-z. 2022
The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.
Gil-Nagel A; (...); Gil A
Article. 10.1016/j.yebeh.2022.108711. 2022
The Challenge of Treating Infections Caused by Metallo-ß-Lactamase-Producing Gram-Negative Bacteria: A Narrative Review.
Hidalgo-Tenorio C; (...); Martínez-Martínez L
Article. 10.1007/s40265-024-02102-8. 2024
The positioning of ceftobiprole in Staphylococcus aureus bacteremia.
Membrillo de Novales FJ; (...); Hidalgo-Tenorio C
Article. 10.1093/cid/ciae123. 2024
The role of rapid multiplex molecular syndromic panels in the clinical management of infections in critically ill patients: an experts-opinion document.
Candel, Francisco Javier; (...); Zaragoza, Rafael
Article. 10.1186/s13054-024-05224-3. 2024
The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD).
Badia, Xavier; (...); Valles, Joan-Antoni
Article. 10.1186/s13023-024-03324-5. 2024
Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses.
Alonso-Navarro, Rodrigo; (...); Soriano, Alex
Article. 10.1186/s12879-023-08222-y. 2023
Towards a symbiotic relationship between big data, artificial intelligence, and hospital pharmacy
Del Rio-Bermudez, C; (...); Poveda, JL
Editorial Material. 10.1186/s40545-020-00276-6. 2020
Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die.
Chovi-Trull, Maria; (...); Poveda-Andres, Jose Luis
Article. 10.1136/ejhpharm-2024-004184. 2024
Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019-2021.
Vinuela, Laura; (...); Garcia, Federico
Article. 10.1002/jmv.29287. 2023
Tratamiento y prevención de la viruela del mono.
de la Calle-Prieto F; (...); Membrillo FJ
Article. 10.1016/j.eimc.2022.08.001. 2022
Treatment and prevention of monkeypox
Calle-Prieto, Fernando de la; (...); , TERDDPUGDDIYGDDDDS
Review. 10.1016/j.eimc.2022.08.0010213-005X. 2023
Treatment and prevention of monkeypox.
de la Calle-Prieto, Fernando; (...); Membrillo, Francisco Javier
Article. 10.1016/j.eimce.2022.12.010. 2023
Trends in imported infections among migrants and travellers to Spain: a decade of analysis through the +Redivi network (2012-2022).
Alkaissy Y; (...); Perez-Molina JA
Article. 10.1093/jtm/taae067. 2024
Trends in Imported Malaria during the COVID-19 pandemic, Spain (+Redivi Collaborative Network).
Norman, Francesca F.; (...); Perez-Molina, Jose A.
Article. 10.1093/jtm/taac083. 2022
Unplanned pregnancies and social and partner support during pregnancy in Spanish women living with HIV.
Ruiz-Alguero, Marta; (...); Jarrin, Inma
Article. 10.1111/hiv.13469. 2023
Use of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas disease.
Lozano N; (...); Osuna A
Article. 10.1371/journal.pone.0282814. 2023
VALUE CRITERIA FOR OUTCOMES BASED MANAGED ENTRY AGREEMENT OF CAR-T IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) THROUGH MCDA
Poveda, J. L.; (...); Lizan, L.
Meeting Abstract. 2023
Vertebral osteomyelitis: Clinical, microbiological and radiological characteristics of 116 patients
Gil, JJF; (...); Ivorra, JAR
Article. 10.1016/j.medcli.2019.12.029. 2020
What Do We Know about Candida auris ? State of the Art, Knowledge Gaps, and Future Directions.
Garcia-Bustos V; (...); Pemán J
Article. 10.3390/microorganisms9102177. 2021
Whether to make decisions "on the fly" regarding treatment for SARS-CoV-2 infection
de Medrano, VAL, de Lucas, EM, Lleti, MS
Letter. 10.1016/j.rce.2020.04.004. 2020